TimesSquare Capital Management LLC cut its holdings in Chemed Co. (NYSE:CHE - Free Report) by 96.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 6,290 shares of the company's stock after selling 160,845 shares during the period. TimesSquare Capital Management LLC's holdings in Chemed were worth $3,332,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also modified their holdings of CHE. International Assets Investment Management LLC acquired a new position in Chemed during the 3rd quarter valued at about $437,150,000. FMR LLC raised its position in shares of Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after buying an additional 45,917 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of Chemed by 114.1% in the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company's stock worth $39,554,000 after purchasing an additional 39,791 shares in the last quarter. Thrivent Financial for Lutherans increased its stake in Chemed by 25.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 146,017 shares of the company's stock valued at $87,752,000 after buying an additional 29,445 shares during the period. Finally, Aureus Asset Management LLC lifted its position in Chemed by 3,147.2% in the 3rd quarter. Aureus Asset Management LLC now owns 29,939 shares of the company's stock worth $17,993,000 after buying an additional 29,017 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.
Chemed Stock Performance
Shares of Chemed stock traded down $5.77 during trading on Friday, hitting $544.34. 66,843 shares of the stock traded hands, compared to its average volume of 87,997. The company has a fifty day moving average price of $542.64 and a two-hundred day moving average price of $563.96. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $654.62. The stock has a market cap of $8.19 billion, a P/E ratio of 27.51, a PEG ratio of 2.17 and a beta of 0.48.
Chemed Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.37%. The ex-dividend date is Monday, February 24th. Chemed's dividend payout ratio is currently 10.11%.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on CHE shares. Royal Bank of Canada reduced their price target on Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th.
View Our Latest Stock Report on CHE
Insiders Place Their Bets
In other Chemed news, VP Brian C. Judkins purchased 145 shares of the company's stock in a transaction on Monday, December 30th. The shares were bought at an average cost of $519.50 per share, with a total value of $75,327.50. Following the transaction, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the sale, the chief executive officer now owns 101,735 shares in the company, valued at approximately $58,270,755.95. This represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 3.32% of the company's stock.
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Stories
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
